TSLA
Tesla
-- 248.710 NVDA
NVIDIA
-- 117.700 MU
Micron Technology
-- 94.720 NKE
Nike
-- 67.940 PLTR
Palantir
-- 90.960 
$Inhibikase Therapeutics (IKT.US)$ learn from $Amedisys (AME...
$Inhibikase Therapeutics (IKT.US)$
learn from
$Amedisys (AMED.US)$
$AMC Entertainment (AMC.US)$
$Fulcrum Therapeutics (FULC.US)$
learn from
$Amedisys (AMED.US)$
$AMC Entertainment (AMC.US)$
$Fulcrum Therapeutics (FULC.US)$
JonesTrading analyst Soumit Roy initiates coverage on Inhibikase Therapeutics (NASDAQ:IKT) with a Buy rating and announces Price Target of $12.
Disclaimer: Community is offered by Moomoo Technologies Inc. and is for educational purposes only.
Read more
Comment
Sign in to post a comment